Warfarin dose requirement and cytochrome P450 2C9 and Vitamin K epoxide reductase complex subunit 1-1639 genetic polymorphisms in Thai patients
Aims: The purposes of this study were to investigate the influence of genetic polymorphisms of cytochrome P450 2C9 (CYP2C9)FNx013 and Vitamin K epoxide reductase complex subunit 1-1639 (VKORC1-1639) G >A and patient′s characteristics on warfarin dose requirement and to establish an equation for p...
Main Authors: | Burassakorn Subsuphan, Chatchai Chinpaisal, Manat Pongchaidecha, Wibun Phanthabordeekorn, Surawut Watana |
---|---|
Format: | Article |
Language: | English |
Published: |
Archives of Global Professionals
2016-01-01
|
Series: | Archives of Pharmacy Practice |
Subjects: | |
Online Access: | http://www.archivepp.com/article.asp?issn=2045-080X;year=2016;volume=7;issue=1;spage=18;epage=25;aulast=Subsuphan |
Similar Items
-
Warfarin Resistance: A Case Report
by: Uğur Gönlügür, et al.
Published: (2019-03-01) -
Evaluation and clinical implications of interactions between compound Danshen dropping pill and warfarin associated with the epoxide hydrolase gene
by: Xixi Chen, et al.
Published: (2023-05-01) -
Influence of Shenxiong Glucose Injection on the Activities of Six CYP Isozymes and Metabolism of Warfarin in Rats Assessed Using Probe Cocktail and Pharmacokinetic Approaches
by: Jia Sun, et al.
Published: (2017-11-01) -
The effect of ‘cytochrome P-450 2C9’ and ‘vitamin K epoxide reductase complex 1’ genetic polymorphism upon oral anticoagulation requirements
by: Hossam Y.K Mohammed, et al.
Published: (2018-01-01) -
Association between Cytochrome P450 2 C9 and Vitamin K Epoxide Reductase Complex Subunit 1 Polymorphisms with Warfarin dose among Iranian Patients
by: Reyhaneh Kameli, et al.
Published: (2016-11-01)